(Information sent by the signatory company)

SAN DIEGO & TOKYO & WETTEREN, Belgium, March 14, 2023/PRNewswire/ — Ajinomoto Bio-Pharma Services (“Aji Bio-Pharma”), a leading provider of biopharmaceutical contract development and manufacturing services, received three awards from CDMO leadership in the Capabilities, Compatibility and Experience categories in the General and Big Pharma respondent groups.

Founded in 2011, the CDMO Leadership Awards recognize the best outsourcing partners. The awards, renamed the CMO Leadership Awards, are presented by Life Science Leader magazine and Industry Standard Research. 72 contract manufacturers were evaluated on 23 performance metrics in ISR’s annual Contract Manufacturing Quality Benchmarking survey. Respondents only rate companies with whom they have worked on an outsourced project in the last 18 months. Based on the ratings of these recent outsourced projects provided by the sponsors, this experiential feedback is analyzed by size of the sponsoring company to reveal the leading CDMOs in different performance categories.

“For more than a decade, these awards have been the most significant for biopharmaceutical organizations striving to obtain optimal results from their outsourcing activities. Our research arm, ISR Reports, which only surveys drug sponsors who have worked directly and recently with specific CDMOs, ensures the validity of these results. Our winners are your outsourcing gold medalists,” explained Louis Garguilo, editor-in-chief and conference chair, Outsourced Pharma.

“We are proud to be recognized by our partners as we continue to invest in new technologies, quality systems, and facilities to increase our capabilities and expertise to meet the needs of our customers. We are proud to know that our efforts are helping countless patients for the coming years,” said Yasuyuki Otake, CEO of the Biopharmaceutical Services Department.

About Ajinomoto Bio-Pharma Services

Ajinomoto Bio-Pharma Services is a fully integrated contract development and manufacturing organization with locations in Belgium, USA, Japan and India, providing end-to-end development, cGMP manufacturing and aseptic fill-finishing services for APIs and small molecule intermediates and big. Ajinomoto Bio-Pharma Services offers a wide range of innovative platforms and capabilities for preclinical and pilot programs in commercial quantities, including Corynex® protein expression technology, oligonucleotide synthesis, antibody drug conjugations (ADCs), high potency APIs (HPAPI), biocatalysis, continuous flow manufacturing, and more. Ajinomoto Bio-Pharma Services is dedicated to providing a high level of quality and service to meet the needs of our customers. More information: www.AjiBio-Pharma.com

Logo – https://mma.prnewswire.com/media/751177/Aji_BioPharma_Logo.jpg

View original content: https://www.prnewswire.com/news-releases/ajinomoto-bio-pharma-services-recibe-tres-premios-de-liderazgo-cdmo-301771843.html